TD Cowen Just Upgraded UnitedHealth Stock. Here’s Why.

Barchart
Open on Barchart
TD Cowen Just Upgraded UnitedHealth Stock. Here’s Why.

TD Cowen’s senior analyst Ryan Langston upgraded UnitedHealth (UNH) shares to Buy on Nov. 20, naming the insurer his top stock idea for 2027.

In his research note, Langston also raised his price target for UNH to $455, indicating potential for another 33% upside from current levels. 

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

TD Cowen’s bullish call arrives at a time when souring broader market sentiment has driven UNH stock down some 20% versus its October High. 

www.barchart.com

TD Cowen’s Bullish Thesis for UnitedHealth Stock

Langston sees a credible path to mid-to-high-teens growth in earnings per share (EPS) through at least 2028.

According to him, UnitedHealth has structured its 2027 Medicare Advantage benefits to help boost profitability. Meanwhile, in commercial insurance and Medicaid, higher premium and government payments are starting to catch up with rising medical costs,

TD Cowen also expects cost cuts and renegotiated contracts to expand Optum Health margin over the long-term.  

In short, the firm recommends owning UnitedHealth shares because the company has several ways to grow earnings even if one of its businesses takes longer to recover.

What Else Makes UNH Shares Attractive?

TD Cowen’s upwardly revised price target is based on a 16.5x multiple on projected 2028 earnings.

That implies per-share earnings of about $27.6, with Langston signaling $2 per share of additional earnings potential beyond his forecast if Optum Health and the commercial and Medicaid divisions fully recover. 

His upgrade also comes after a selloff fueled by a federal proposal that could expand Medicare Advantage audits and expose insurers to repayment demands.

But the analyst sees that as a “manageable” risk – one that’s already priced into UnitedHealth stock at current levels. A healthy 2.7% dividend yield makes UNH even more attractive as a long-term holding heading into 2027. 

Wall Street’s View on UnitedHealth Group

Other Wall Street analysts agree with Langston’s bullish stance on UnitedHealth Group for the next 12 months. 

According to Barchart, the consensus rating on UNH shares remains at “Strong Buy,” with the mean price target of about $474 indicating recent weakness will likely prove temporary and the company will rip higher from here in 2027.

www.barchart.com
On the date of publication, Wajeeh Khan did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

TD Cowen Just Upgraded UnitedHealth Stock. Here’s Why. Apple Is Now Worth Over $5 Trillion Without Betting Big on AI Data Centers. AAPL Stock Now Trades Near Wall Street’s Targets. 2 ETFs to Consider in a Market Where Nearly All Stocks Look Dangerous SEC Investigates Nvidia Over Potential Misleading Investor Disclosures. That Should Not Be a Deterrent for Owning NVDA Stock.